These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 26767854)

  • 1. The antibacterial effect of fatty acids on Helicobacter pylori infection.
    Jung SW; Lee SW
    Korean J Intern Med; 2016 Jan; 31(1):30-5. PubMed ID: 26767854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo treatment of Helicobacter pylori infection with liposomal linolenic acid reduces colonization and ameliorates inflammation.
    Thamphiwatana S; Gao W; Obonyo M; Zhang L
    Proc Natl Acad Sci U S A; 2014 Dec; 111(49):17600-5. PubMed ID: 25422427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Helicobacter pylori and Antibiotic Resistance, A Continuing and Intractable Problem.
    Hu Y; Zhang M; Lu B; Dai J
    Helicobacter; 2016 Oct; 21(5):349-63. PubMed ID: 26822340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibacterial activities of liposomal linolenic acids against antibiotic-resistant Helicobacter pylori.
    Obonyo M; Zhang L; Thamphiwatana S; Pornpattananangkul D; Fu V; Zhang L
    Mol Pharm; 2012 Sep; 9(9):2677-85. PubMed ID: 22827534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An Overview of Helicobacter pylori Infection.
    FitzGerald R; Smith SM
    Methods Mol Biol; 2021; 2283():1-14. PubMed ID: 33765303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of Helicobacter pylori-positive and Helicobacter pylori-negative gastric mucosa-associated lymphoid tissue lymphoma and their influence on clinical outcome.
    Choi YJ; Kim N; Paik JH; Kim JM; Lee SH; Park YS; Hwang JH; Kim JW; Jeong SH; Lee DH; Jung HC
    Helicobacter; 2013 Jun; 18(3):197-205. PubMed ID: 23305046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Curcumin as a potential therapeutic candidate for Helicobacter pylori associated diseases.
    Sarkar A; De R; Mukhopadhyay AK
    World J Gastroenterol; 2016 Mar; 22(9):2736-48. PubMed ID: 26973412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological therapy used in the elimination of Helicobacter pylori infection: a review.
    Dos Santos AA; Carvalho AA
    World J Gastroenterol; 2015 Jan; 21(1):139-54. PubMed ID: 25574087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial susceptibility testing for Helicobacter pylori in times of increasing antibiotic resistance.
    Smith SM; O'Morain C; McNamara D
    World J Gastroenterol; 2014 Aug; 20(29):9912-21. PubMed ID: 25110421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review: Pharmacological ins and outs of medicinal plants against Helicobacter pylori: A review.
    Zaidi SF; Muhammad JS; Usmanghani K; Sugiyama T
    Pak J Pharm Sci; 2015 May; 28(3 Suppl):1171-6. PubMed ID: 26051742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Helicobacter pylori: microbiology and interactions with gastrointestinal microflora.
    Dzierzanowska-Fangrat K; Dzierzanowska D
    J Physiol Pharmacol; 2006 Sep; 57 Suppl 3():5-14. PubMed ID: 17033102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Helicobacter pylori: past, current and future treatment strategies with gastroretentive drug delivery systems.
    Verma A; Dubey J; Hegde RR; Rastogi V; Pandit JK
    J Drug Target; 2016 Dec; 24(10):897-915. PubMed ID: 27027827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Floating-bioadhesive gastroretentive Caesalpinia pulcherrima-based beads of amoxicillin trihydrate for Helicobacter pylori eradication.
    Thombre NA; Gide PS
    Drug Deliv; 2016; 23(2):405-19. PubMed ID: 24870198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of amalgam dental fillings on the frequency of Helicobacter pylori infection and H. pylori eradication rates in patients treated with concomitant, quadruple, and levofloxacin-based therapies.
    Aktaş B; Başyiğit S; Yüksel O; Akkan T; Atbaşı ST; Uzman M; Yılmaz B; Şimşek G; Nazlıgül Y
    Eur J Gastroenterol Hepatol; 2015 Jul; 27(7):769-75. PubMed ID: 25919773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of clarithromycin-resistant Helicobacter pylori strains in gastric mucosa-associated lymphoid tissue lymphoma patients.
    Bilgilier C; Simonitsch-Klupp I; Kiesewetter B; Raderer M; Dolak W; Makristathis A; Steininger C
    Ann Hematol; 2016 Jun; 95(7):1115-20. PubMed ID: 27091350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of Helicobacter pylori infection in gastric carcinogenesis: Current knowledge and future directions.
    Sokic-Milutinovic A; Alempijevic T; Milosavljevic T
    World J Gastroenterol; 2015 Nov; 21(41):11654-72. PubMed ID: 26556993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibiotic therapy for Helicobacter pylori.
    Collins J; Ali-Ibrahim A; Smoot DT
    Med Clin North Am; 2006 Nov; 90(6):1125-40. PubMed ID: 17116440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polysaccharides as Bacterial Antiadhesive Agents and "Smart" Constituents for Improved Drug Delivery Systems Against Helicobacter pylori Infection.
    Menchicchi B; Hensel A; Goycoolea FM
    Curr Pharm Des; 2015; 21(33):4888-906. PubMed ID: 26290206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of plaunotol in combination with clarithromycin against clarithromycin-resistant Helicobacter pylori in vitro and in vivo.
    Sasaki M; Mizoshita T; Mizushima T; Inoue H; Kamiya T; Kataoka H; Ogaswara N; Wada T; Kubota E; Mori Y; Shimura T; Hirata H; Ando K; Okamoto Y; Ohara H; Nakao H; Joh T
    J Antimicrob Chemother; 2007 Nov; 60(5):1060-3. PubMed ID: 17827146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Helicobacter pylori-negative gastric mucosa-associated lymphoid tissue lymphomas: A review.
    Asano N; Iijima K; Koike T; Imatani A; Shimosegawa T
    World J Gastroenterol; 2015 Jul; 21(26):8014-20. PubMed ID: 26185372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.